Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.
Phenylephrine was granted FDA approval in 1939.
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation ...
Aarhus University Hospital, Department of Anaesthesiology, Aarhus, Denmark
Assiut University, Assiut, Egypt
Yale-New Haven Hospital, New Haven, Connecticut, United States
Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea, Republic of
Kasr Alaini Hospital, Cairo, Egypt
Suez Canal University, Ismailia, Egypt
Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
Carilion Clinic, Roanoke, Virginia, United States
The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
Mount Sinai Hospital, Toronto, Ontario, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.